Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 18:11:57.
doi: 10.3389/fphar.2020.00057. eCollection 2020.

Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors

Affiliations
Review

Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors

Angélica Del Pilar Escobar et al. Front Pharmacol. .

Abstract

The strength of goal-oriented behaviors is regulated by midbrain dopamine neurons. Dysfunctions of dopaminergic circuits are observed in drug addiction and obsessive-compulsive disorder. Compulsive behavior is a feature that both disorders share, which is associated to a heightened dopamine neurotransmission. The activity of midbrain dopamine neurons is principally regulated by the homeostatic action of dopamine through D2 receptors (D2R) that decrease the firing of neurons as well as dopamine synthesis and release. Dopamine transmission is also regulated by heterologous neurotransmitter systems such as the kappa opioid system, among others. Much of our current knowledge of the kappa opioid system and its influence on dopamine transmission comes from preclinical animal models of brain diseases. In 1988, using cerebral microdialysis, it was shown that the acute activation of the Kappa Opioid Receptors (KOR) decreases synaptic levels of dopamine in the striatum. This inhibitory effect of KOR opposes to the facilitating influence of drugs of abuse on dopamine release, leading to the proposition of the use of KOR agonists as pharmacological therapy for compulsive drug intake. Surprisingly, 30 years later, KOR antagonists are instead proposed to treat drug addiction. What may have happened during these years that generated this drastic change of paradigm? The collected evidence suggested that the effect of KOR on synaptic dopamine levels is complex, depending on the frequency of KOR activation and timing with other incoming stimuli to dopamine neurons, as well as sex and species differences. Conversely to its acute effect, chronic KOR activation seems to facilitate dopamine neurotransmission and dopamine-mediated behaviors. The opposing actions exerted by acute versus chronic KOR activation have been associated with an initial aversive and a delayed rewarding effect, during the exposure to drugs of abuse. Compulsive behaviors induced by repeated activation of D2R are also potentiated by the sustained co-activation of KOR, which correlates with decreased synaptic levels of dopamine and sensitized D2R. Thus, the time-dependent activation of KOR impacts directly on dopamine levels affecting the tuning of motivated behaviors. This review analyzes the contribution of the kappa opioid system to the dopaminergic correlates of compulsive behaviors.

Keywords: amphetamine; compulsivity; dopamine; kappa opioid receptor; locomotor sensitization; quinpirole.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Integrative scheme of Kappa Opioid Receptors (KOR) control on direct (D1R) and indirect (D2R) striatal phatways. (A) KOR are located pre-sinaptically on dopamine terminals and post sinaptically in medium-sized neurons (MSNs). Its activation controls dopamine extracellular levels and its localization promotes the interaction with dopamine transporter (DAT) and dopamine D2 receptors. (B) The repeated exposure to a psychostimulant is accompanied by an increase in both dopamine extracellular levels and dynorphin. The activation of D1 and D2 receptors switch the balance to the D1R direct pathway promoting locomotor sensitization. (C) The co-administration of quinpirole and U69593 is accompanied by a decrease in dopamine extracellular levels. The concomitant activation of KOR and D2 receptors debilitates the D2 indirect pathway inducing compulsive behavior.

References

    1. Abraham A. D., Fontaine H. M., Song A. J., Andrews M. M., Baird M. A., Kieffer B. L., et al. (2017). Kappa opioid receptor activation in dopamine neurons disrupts behavioral inhibition. Neuropsychopharmacology 43 (2), 362–372. 10.1038/npp.2017.133 - DOI - PMC - PubMed
    1. Abraham A. D., Schattauer S. S., Reichard K. L., Cohen J. H., Fontaine H. M., Song A. J., et al. (2018). Estrogen regulation of GRK2 inactivates kappa opioid receptor signaling mediating analgesia, but not aversion. J. Neurosci. 38 (37), 8031–8043. 10.1523/JNEUROSCI.0653-18.2018 - DOI - PMC - PubMed
    1. Asaoka N., Nishitani N., Kinoshita H., Nagai Y., Hatakama H., Nagayasu K., et al. (2019). An adenosine A2A receptor antagonist improves multiple symptoms of repeated quinpirole-induced psychosis. eNeuro 6 (1), 1–16. ENEURO.0366-18.2019. 10.1523/ENEURO.0366-18.2019 - DOI - PMC - PubMed
    1. Atigari D. V., Uprety R., Pasternak G. W., Majumdar S., Kivell B. M. (2019). MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats. Neuropharmacology 150, 217–228. 10.1016/j.neuropharm.2019.02.010 - DOI - PMC - PubMed
    1. Azocar V. H., Sepúlveda G., Ruiz C., Aguilera C., Andrés M. E., Fuentealba J. A. (2019). The blocking of kappa-opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization. J. Neurochem. 148, 348–358. 10.1111/jnc.14612 - DOI - PubMed

LinkOut - more resources